ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Molecular Point of Care (POC) Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-23C13208
Home | Market Reports | Health| Nursing
Global Molecular Point of Care POC Market Research Report 2023
BUY CHAPTERS

Global Molecular Point of Care (POC) Market Research Report 2025

Code: QYRE-Auto-23C13208
Report
April 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Aidian
Akonni Biosystems
Biocartis
BioMérieux SA
Cepheid Inc
Curetis
DiaSorin
GenMark Diagnostics
Greiner Bio One GmbH
Meridian Bioscience Inc.
Mesa Biotech, Inc.
Qiagen NV
Quantumdx Group
Quidel Corporation
Roche
Sekisui Diagnostics, LLC
T2 Biosystems
binx health, inc.
Credo Bioscience

Molecular Point of Care (POC) Market

The global market for Molecular Point of Care (POC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Molecular Point of Care (POC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Molecular Point of Care (POC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Molecular Point of Care (POC) in Clinical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Molecular Point of Care (POC) include Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience, Curetis NV, DiaSorin S.p.A, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Point of Care (POC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Point of Care (POC).
The Molecular Point of Care (POC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Point of Care (POC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Point of Care (POC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Molecular Point of Care (POC) Market Report

Report Metric Details
Report Name Molecular Point of Care (POC) Market
Segment by Type
  • Respiratory
  • Other
Segment by Application
  • Clinical
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience, Curetis NV, DiaSorin S.p.A, GenMark Diagnostics, Greiner Bio-One GmbH, Meridian Bioscience, Inc., Mesa Biotech, Inc., QIAGEN NV, QuantuMDx Group, Quidel Corporation, Roche, Sekisui Diagnostics LLC, T2 Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Molecular Point of Care (POC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Point of Care (POC) Market report?

Ans: The main players in the Molecular Point of Care (POC) Market are Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience, Curetis NV, DiaSorin S.p.A, GenMark Diagnostics, Greiner Bio-One GmbH, Meridian Bioscience, Inc., Mesa Biotech, Inc., QIAGEN NV, QuantuMDx Group, Quidel Corporation, Roche, Sekisui Diagnostics LLC, T2 Biosystems

What are the Application segmentation covered in the Molecular Point of Care (POC) Market report?

Ans: The Applications covered in the Molecular Point of Care (POC) Market report are Clinical, Research

What are the Type segmentation covered in the Molecular Point of Care (POC) Market report?

Ans: The Types covered in the Molecular Point of Care (POC) Market report are Respiratory, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Point of Care (POC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Respiratory
1.2.3 Other
1.3 Market by Application
1.3.1 Global Molecular Point of Care (POC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Point of Care (POC) Market Perspective (2020-2031)
2.2 Global Molecular Point of Care (POC) Growth Trends by Region
2.2.1 Global Molecular Point of Care (POC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Point of Care (POC) Historic Market Size by Region (2020-2025)
2.2.3 Molecular Point of Care (POC) Forecasted Market Size by Region (2026-2031)
2.3 Molecular Point of Care (POC) Market Dynamics
2.3.1 Molecular Point of Care (POC) Industry Trends
2.3.2 Molecular Point of Care (POC) Market Drivers
2.3.3 Molecular Point of Care (POC) Market Challenges
2.3.4 Molecular Point of Care (POC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Point of Care (POC) Players by Revenue
3.1.1 Global Top Molecular Point of Care (POC) Players by Revenue (2020-2025)
3.1.2 Global Molecular Point of Care (POC) Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Point of Care (POC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Point of Care (POC) Revenue
3.4 Global Molecular Point of Care (POC) Market Concentration Ratio
3.4.1 Global Molecular Point of Care (POC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Point of Care (POC) Revenue in 2024
3.5 Global Key Players of Molecular Point of Care (POC) Head office and Area Served
3.6 Global Key Players of Molecular Point of Care (POC), Product and Application
3.7 Global Key Players of Molecular Point of Care (POC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Point of Care (POC) Breakdown Data by Type
4.1 Global Molecular Point of Care (POC) Historic Market Size by Type (2020-2025)
4.2 Global Molecular Point of Care (POC) Forecasted Market Size by Type (2026-2031)
5 Molecular Point of Care (POC) Breakdown Data by Application
5.1 Global Molecular Point of Care (POC) Historic Market Size by Application (2020-2025)
5.2 Global Molecular Point of Care (POC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Point of Care (POC) Market Size (2020-2031)
6.2 North America Molecular Point of Care (POC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Point of Care (POC) Market Size by Country (2020-2025)
6.4 North America Molecular Point of Care (POC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Point of Care (POC) Market Size (2020-2031)
7.2 Europe Molecular Point of Care (POC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Point of Care (POC) Market Size by Country (2020-2025)
7.4 Europe Molecular Point of Care (POC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Point of Care (POC) Market Size (2020-2031)
8.2 Asia-Pacific Molecular Point of Care (POC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Point of Care (POC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Point of Care (POC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Point of Care (POC) Market Size (2020-2031)
9.2 Latin America Molecular Point of Care (POC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Point of Care (POC) Market Size by Country (2020-2025)
9.4 Latin America Molecular Point of Care (POC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Point of Care (POC) Market Size (2020-2031)
10.2 Middle East & Africa Molecular Point of Care (POC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Point of Care (POC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Point of Care (POC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Point of Care (POC) Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Aidian Oy
11.2.1 Aidian Oy Company Details
11.2.2 Aidian Oy Business Overview
11.2.3 Aidian Oy Molecular Point of Care (POC) Introduction
11.2.4 Aidian Oy Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.2.5 Aidian Oy Recent Development
11.3 Akonni Biosystems
11.3.1 Akonni Biosystems Company Details
11.3.2 Akonni Biosystems Business Overview
11.3.3 Akonni Biosystems Molecular Point of Care (POC) Introduction
11.3.4 Akonni Biosystems Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.3.5 Akonni Biosystems Recent Development
11.4 binx health, inc.
11.4.1 binx health, inc. Company Details
11.4.2 binx health, inc. Business Overview
11.4.3 binx health, inc. Molecular Point of Care (POC) Introduction
11.4.4 binx health, inc. Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.4.5 binx health, inc. Recent Development
11.5 Biocartis NV
11.5.1 Biocartis NV Company Details
11.5.2 Biocartis NV Business Overview
11.5.3 Biocartis NV Molecular Point of Care (POC) Introduction
11.5.4 Biocartis NV Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.5.5 Biocartis NV Recent Development
11.6 bioMérieux SA
11.6.1 bioMérieux SA Company Details
11.6.2 bioMérieux SA Business Overview
11.6.3 bioMérieux SA Molecular Point of Care (POC) Introduction
11.6.4 bioMérieux SA Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.6.5 bioMérieux SA Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Molecular Point of Care (POC) Introduction
11.7.4 Cepheid Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.7.5 Cepheid Recent Development
11.8 Credo Bioscience
11.8.1 Credo Bioscience Company Details
11.8.2 Credo Bioscience Business Overview
11.8.3 Credo Bioscience Molecular Point of Care (POC) Introduction
11.8.4 Credo Bioscience Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.8.5 Credo Bioscience Recent Development
11.9 Curetis NV
11.9.1 Curetis NV Company Details
11.9.2 Curetis NV Business Overview
11.9.3 Curetis NV Molecular Point of Care (POC) Introduction
11.9.4 Curetis NV Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.9.5 Curetis NV Recent Development
11.10 DiaSorin S.p.A
11.10.1 DiaSorin S.p.A Company Details
11.10.2 DiaSorin S.p.A Business Overview
11.10.3 DiaSorin S.p.A Molecular Point of Care (POC) Introduction
11.10.4 DiaSorin S.p.A Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.10.5 DiaSorin S.p.A Recent Development
11.11 GenMark Diagnostics
11.11.1 GenMark Diagnostics Company Details
11.11.2 GenMark Diagnostics Business Overview
11.11.3 GenMark Diagnostics Molecular Point of Care (POC) Introduction
11.11.4 GenMark Diagnostics Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.11.5 GenMark Diagnostics Recent Development
11.12 Greiner Bio-One GmbH
11.12.1 Greiner Bio-One GmbH Company Details
11.12.2 Greiner Bio-One GmbH Business Overview
11.12.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Introduction
11.12.4 Greiner Bio-One GmbH Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.12.5 Greiner Bio-One GmbH Recent Development
11.13 Meridian Bioscience, Inc.
11.13.1 Meridian Bioscience, Inc. Company Details
11.13.2 Meridian Bioscience, Inc. Business Overview
11.13.3 Meridian Bioscience, Inc. Molecular Point of Care (POC) Introduction
11.13.4 Meridian Bioscience, Inc. Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.13.5 Meridian Bioscience, Inc. Recent Development
11.14 Mesa Biotech, Inc.
11.14.1 Mesa Biotech, Inc. Company Details
11.14.2 Mesa Biotech, Inc. Business Overview
11.14.3 Mesa Biotech, Inc. Molecular Point of Care (POC) Introduction
11.14.4 Mesa Biotech, Inc. Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.14.5 Mesa Biotech, Inc. Recent Development
11.15 QIAGEN NV
11.15.1 QIAGEN NV Company Details
11.15.2 QIAGEN NV Business Overview
11.15.3 QIAGEN NV Molecular Point of Care (POC) Introduction
11.15.4 QIAGEN NV Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.15.5 QIAGEN NV Recent Development
11.16 QuantuMDx Group
11.16.1 QuantuMDx Group Company Details
11.16.2 QuantuMDx Group Business Overview
11.16.3 QuantuMDx Group Molecular Point of Care (POC) Introduction
11.16.4 QuantuMDx Group Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.16.5 QuantuMDx Group Recent Development
11.17 Quidel Corporation
11.17.1 Quidel Corporation Company Details
11.17.2 Quidel Corporation Business Overview
11.17.3 Quidel Corporation Molecular Point of Care (POC) Introduction
11.17.4 Quidel Corporation Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.17.5 Quidel Corporation Recent Development
11.18 Roche
11.18.1 Roche Company Details
11.18.2 Roche Business Overview
11.18.3 Roche Molecular Point of Care (POC) Introduction
11.18.4 Roche Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.18.5 Roche Recent Development
11.19 Sekisui Diagnostics LLC
11.19.1 Sekisui Diagnostics LLC Company Details
11.19.2 Sekisui Diagnostics LLC Business Overview
11.19.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Introduction
11.19.4 Sekisui Diagnostics LLC Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.19.5 Sekisui Diagnostics LLC Recent Development
11.20 T2 Biosystems
11.20.1 T2 Biosystems Company Details
11.20.2 T2 Biosystems Business Overview
11.20.3 T2 Biosystems Molecular Point of Care (POC) Introduction
11.20.4 T2 Biosystems Revenue in Molecular Point of Care (POC) Business (2020-2025)
11.20.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Aidian
Akonni Biosystems
Biocartis
BioMérieux SA
Cepheid Inc
Curetis
DiaSorin
GenMark Diagnostics
Greiner Bio One GmbH
Meridian Bioscience Inc.
Mesa Biotech, Inc.
Qiagen NV
Quantumdx Group
Quidel Corporation
Roche
Sekisui Diagnostics, LLC
T2 Biosystems
binx health, inc.
Credo Bioscience
List of Tables
 Table 1. Global Molecular Point of Care (POC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Respiratory
 Table 3. Key Players of Other
 Table 4. Global Molecular Point of Care (POC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Molecular Point of Care (POC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Molecular Point of Care (POC) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Molecular Point of Care (POC) Market Share by Region (2020-2025)
 Table 8. Global Molecular Point of Care (POC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Molecular Point of Care (POC) Market Share by Region (2026-2031)
 Table 10. Molecular Point of Care (POC) Market Trends
 Table 11. Molecular Point of Care (POC) Market Drivers
 Table 12. Molecular Point of Care (POC) Market Challenges
 Table 13. Molecular Point of Care (POC) Market Restraints
 Table 14. Global Molecular Point of Care (POC) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Molecular Point of Care (POC) Market Share by Players (2020-2025)
 Table 16. Global Top Molecular Point of Care (POC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point of Care (POC) as of 2024)
 Table 17. Ranking of Global Top Molecular Point of Care (POC) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Molecular Point of Care (POC) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Molecular Point of Care (POC), Headquarters and Area Served
 Table 20. Global Key Players of Molecular Point of Care (POC), Product and Application
 Table 21. Global Key Players of Molecular Point of Care (POC), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Molecular Point of Care (POC) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Molecular Point of Care (POC) Revenue Market Share by Type (2020-2025)
 Table 25. Global Molecular Point of Care (POC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Molecular Point of Care (POC) Revenue Market Share by Type (2026-2031)
 Table 27. Global Molecular Point of Care (POC) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Molecular Point of Care (POC) Revenue Market Share by Application (2020-2025)
 Table 29. Global Molecular Point of Care (POC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Molecular Point of Care (POC) Revenue Market Share by Application (2026-2031)
 Table 31. North America Molecular Point of Care (POC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Molecular Point of Care (POC) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Molecular Point of Care (POC) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Molecular Point of Care (POC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Molecular Point of Care (POC) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Molecular Point of Care (POC) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Molecular Point of Care (POC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Molecular Point of Care (POC) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Molecular Point of Care (POC) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Molecular Point of Care (POC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Molecular Point of Care (POC) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Molecular Point of Care (POC) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Molecular Point of Care (POC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Molecular Point of Care (POC) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Molecular Point of Care (POC) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Molecular Point of Care (POC) Product
 Table 49. Abbott Laboratories Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. Aidian Oy Company Details
 Table 52. Aidian Oy Business Overview
 Table 53. Aidian Oy Molecular Point of Care (POC) Product
 Table 54. Aidian Oy Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 55. Aidian Oy Recent Development
 Table 56. Akonni Biosystems Company Details
 Table 57. Akonni Biosystems Business Overview
 Table 58. Akonni Biosystems Molecular Point of Care (POC) Product
 Table 59. Akonni Biosystems Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 60. Akonni Biosystems Recent Development
 Table 61. binx health, inc. Company Details
 Table 62. binx health, inc. Business Overview
 Table 63. binx health, inc. Molecular Point of Care (POC) Product
 Table 64. binx health, inc. Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 65. binx health, inc. Recent Development
 Table 66. Biocartis NV Company Details
 Table 67. Biocartis NV Business Overview
 Table 68. Biocartis NV Molecular Point of Care (POC) Product
 Table 69. Biocartis NV Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 70. Biocartis NV Recent Development
 Table 71. bioMérieux SA Company Details
 Table 72. bioMérieux SA Business Overview
 Table 73. bioMérieux SA Molecular Point of Care (POC) Product
 Table 74. bioMérieux SA Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 75. bioMérieux SA Recent Development
 Table 76. Cepheid Company Details
 Table 77. Cepheid Business Overview
 Table 78. Cepheid Molecular Point of Care (POC) Product
 Table 79. Cepheid Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 80. Cepheid Recent Development
 Table 81. Credo Bioscience Company Details
 Table 82. Credo Bioscience Business Overview
 Table 83. Credo Bioscience Molecular Point of Care (POC) Product
 Table 84. Credo Bioscience Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 85. Credo Bioscience Recent Development
 Table 86. Curetis NV Company Details
 Table 87. Curetis NV Business Overview
 Table 88. Curetis NV Molecular Point of Care (POC) Product
 Table 89. Curetis NV Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 90. Curetis NV Recent Development
 Table 91. DiaSorin S.p.A Company Details
 Table 92. DiaSorin S.p.A Business Overview
 Table 93. DiaSorin S.p.A Molecular Point of Care (POC) Product
 Table 94. DiaSorin S.p.A Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 95. DiaSorin S.p.A Recent Development
 Table 96. GenMark Diagnostics Company Details
 Table 97. GenMark Diagnostics Business Overview
 Table 98. GenMark Diagnostics Molecular Point of Care (POC) Product
 Table 99. GenMark Diagnostics Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 100. GenMark Diagnostics Recent Development
 Table 101. Greiner Bio-One GmbH Company Details
 Table 102. Greiner Bio-One GmbH Business Overview
 Table 103. Greiner Bio-One GmbH Molecular Point of Care (POC) Product
 Table 104. Greiner Bio-One GmbH Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 105. Greiner Bio-One GmbH Recent Development
 Table 106. Meridian Bioscience, Inc. Company Details
 Table 107. Meridian Bioscience, Inc. Business Overview
 Table 108. Meridian Bioscience, Inc. Molecular Point of Care (POC) Product
 Table 109. Meridian Bioscience, Inc. Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 110. Meridian Bioscience, Inc. Recent Development
 Table 111. Mesa Biotech, Inc. Company Details
 Table 112. Mesa Biotech, Inc. Business Overview
 Table 113. Mesa Biotech, Inc. Molecular Point of Care (POC) Product
 Table 114. Mesa Biotech, Inc. Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 115. Mesa Biotech, Inc. Recent Development
 Table 116. QIAGEN NV Company Details
 Table 117. QIAGEN NV Business Overview
 Table 118. QIAGEN NV Molecular Point of Care (POC) Product
 Table 119. QIAGEN NV Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 120. QIAGEN NV Recent Development
 Table 121. QuantuMDx Group Company Details
 Table 122. QuantuMDx Group Business Overview
 Table 123. QuantuMDx Group Molecular Point of Care (POC) Product
 Table 124. QuantuMDx Group Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 125. QuantuMDx Group Recent Development
 Table 126. Quidel Corporation Company Details
 Table 127. Quidel Corporation Business Overview
 Table 128. Quidel Corporation Molecular Point of Care (POC) Product
 Table 129. Quidel Corporation Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 130. Quidel Corporation Recent Development
 Table 131. Roche Company Details
 Table 132. Roche Business Overview
 Table 133. Roche Molecular Point of Care (POC) Product
 Table 134. Roche Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 135. Roche Recent Development
 Table 136. Sekisui Diagnostics LLC Company Details
 Table 137. Sekisui Diagnostics LLC Business Overview
 Table 138. Sekisui Diagnostics LLC Molecular Point of Care (POC) Product
 Table 139. Sekisui Diagnostics LLC Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 140. Sekisui Diagnostics LLC Recent Development
 Table 141. T2 Biosystems Company Details
 Table 142. T2 Biosystems Business Overview
 Table 143. T2 Biosystems Molecular Point of Care (POC) Product
 Table 144. T2 Biosystems Revenue in Molecular Point of Care (POC) Business (2020-2025) & (US$ Million)
 Table 145. T2 Biosystems Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Molecular Point of Care (POC) Picture
 Figure 2. Global Molecular Point of Care (POC) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Molecular Point of Care (POC) Market Share by Type: 2024 VS 2031
 Figure 4. Respiratory Features
 Figure 5. Other Features
 Figure 6. Global Molecular Point of Care (POC) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Molecular Point of Care (POC) Market Share by Application: 2024 VS 2031
 Figure 8. Clinical Case Studies
 Figure 9. Research Case Studies
 Figure 10. Molecular Point of Care (POC) Report Years Considered
 Figure 11. Global Molecular Point of Care (POC) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Molecular Point of Care (POC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Molecular Point of Care (POC) Market Share by Region: 2024 VS 2031
 Figure 14. Global Molecular Point of Care (POC) Market Share by Players in 2024
 Figure 15. Global Top Molecular Point of Care (POC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point of Care (POC) as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Molecular Point of Care (POC) Revenue in 2024
 Figure 17. North America Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Molecular Point of Care (POC) Market Share by Country (2020-2031)
 Figure 19. United States Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Molecular Point of Care (POC) Market Share by Country (2020-2031)
 Figure 23. Germany Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Molecular Point of Care (POC) Market Share by Region (2020-2031)
 Figure 31. China Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Molecular Point of Care (POC) Market Share by Country (2020-2031)
 Figure 39. Mexico Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Molecular Point of Care (POC) Market Share by Country (2020-2031)
 Figure 43. Turkey Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Molecular Point of Care (POC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Abbott Laboratories Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 47. Aidian Oy Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 48. Akonni Biosystems Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 49. binx health, inc. Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 50. Biocartis NV Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 51. bioMérieux SA Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 52. Cepheid Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 53. Credo Bioscience Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 54. Curetis NV Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 55. DiaSorin S.p.A Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 56. GenMark Diagnostics Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 57. Greiner Bio-One GmbH Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 58. Meridian Bioscience, Inc. Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 59. Mesa Biotech, Inc. Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 60. QIAGEN NV Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 61. QuantuMDx Group Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 62. Quidel Corporation Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 63. Roche Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 64. Sekisui Diagnostics LLC Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 65. T2 Biosystems Revenue Growth Rate in Molecular Point of Care (POC) Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions